Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery by Stenberg, Karin et al.
Stenberg et al. Cost Eff Resour Alloc  (2018) 16:11 
https://doi.org/10.1186/s12962-018-0095-x
RESEARCH
Econometric estimation of WHO-CHOICE 
country-specific costs for inpatient 
and outpatient health service delivery
Karin Stenberg1* , Jeremy A. Lauer1, Georgios Gkountouras2, Christopher Fitzpatrick3 and Anderson Stanciole4
Abstract 
Background: Policy makers require information on costs related to inpatient and outpatient health services to 
inform resource allocation decisions.
Methods: Country data sets were gathered in 2008–2010 through literature reviews, website searches and a public 
call for cost data. Multivariate regression analysis was used to explore the determinants of variability in unit costs 
using data from 30 countries. Two models were designed, with the inpatient and outpatient models drawing upon 
3407 and 9028 observations respectively. Cost estimates are produced at country and regional level, with 95% confi-
dence intervals.
Results: Inpatient costs across 30 countries are significantly associated with the type of hospital, ownership, as well 
as bed occupancy rate, average length of stay, and total number of inpatient admissions. Changes in outpatient costs 
are significantly associated with location, facility ownership and the level of care, as well as to the number of outpa-
tient visits and visits per provider per day.
Conclusions: These updated WHO-CHOICE service delivery unit costs are statistically robust and may be used by 
analysts as inputs for economic analysis. The models can predict country-specific unit costs at different capacity levels 
and in different settings.
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Background
Health planners concerned with evidence-informed deci-
sion making and resource allocation rely on high quality 
information regarding the resources needed to imple-
ment investment strategies, and comparing these against 
current and future budgetary constraints. Information on 
costs is essential to inform discussions around value for 
money and efficiency. Unfortunately cost data is sparse 
in many settings, especially in low- and middle income 
countries, where ambitious health targets are now being 
set for the 2030 Sustainable Development Goals (SDGs). 
Challenges include insufficient allocation and/or inef-
ficient allocation of resources towards health priorities 
[1]. Having access to accurate and reliable information 
on the cost of health services can serve various purposes 
including discussions on affordability and financial sus-
tainability, budgeting, cost-effectiveness and cost–benefit 
analysis [2].
Literature related to estimates on the so-called ‘unit 
costs’ of specific health interventions is a growing field, 
yet the transferability of such findings from one setting to 
another is limited [2, 3]. For example, the Access, Bottle-
necks, Costs and Equity (ABCE) initiative from the Uni-
versity of Washington’s Institute for Health Metrics and 
Evaluation has been collecting primary data on health 
care facility costs. However, the focus has been limited 
to Ghana, Kenya, Uganda and Zambia and there is no 
intention to create generalized global estimates [4–7]. 
Similarly, the recently established Global Health Cost 
Consortium at the University of Washington (https://
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ghcosting.org/) intends to produce unit cost estimates 
that can be adapted to local settings, but its scope is lim-
ited to TB and HIV services, and will not provide cost 
estimates for general inpatient or outpatient care.
To our knowledge, the WHO-CHOICE (CHOosing 
Interventions that are Cost Effective) project is the only 
programme seeking to collect and standardise estimates 
of the costs related to facility-based service delivery, to 
compare these across countries, and to provide country-
specific estimates of facility service costs as a global pub-
lic good. WHO-CHOICE estimates are produced for all 
countries and can therefore be used in settings where no 
local data is available. Estimates are based on modeling 
of primary and secondary data, and are derived from a 
model that provides the best fit according to global data. 
Such models will not yield perfect predictions for all 
countries, and it is therefore maintained that whenever 
good quality country unit cost data is available from a 
representative sample, this should be used rather than 
using the CHOICE predictions.
Under WHO-CHOICE, WHO has collated facility cost 
data from countries since 2000. These data have served 
to inform estimates for country-specific costs related to 
health service utilization—with estimates for cost per inpa-
tient day and outpatient visit. The service delivery unit cost 
estimates are used to support cost-effectiveness analysis 
within the WHO-CHOICE project, among other things.
  • Inpatient day The estimated cost of a hospital bed-
day reflects only the “hotel” component of the hospital 
cost—i.e. it excludes the cost of drugs and diagnostic 
tests but includes costs such as personnel, capital infra-
structure and equipment, laboratory, maintenance and 
other operational costs of the hospital, as well as food 
costs. The intent is to produce a measure that covers 
those components that are assumed to be standardised 
across different diseases and treatments.
  • Outpatient visit Similarly, WHO-CHOICE outpatient 
costs include components not specific to the disease 
or treatment, but those largely assumed to be stand-
ardised across disease conditions for which the care is 
provided: namely personnel, capital infrastructure and 
equipment, laboratory, maintenance and other opera-
tional costs of the health facility. In recognition of the 
fact that costs for equipment, maintenance etc., may 
vary depending on the setting in which care is pro-
vided, inpatient and outpatient care costs are estimated 
for different types of providers and levels of the health 
system.
The use of standardised estimates for the service deliv-
ery component of intervention costs ensures that inter-
ventions can be compared fairly, using consistent price 
assumptions. Inputs into the service production process 
(including technology, prices and production efficiency) 
change over time, and WHO-CHOICE seeks to regularly 
provide updated estimates. WHO-CHOICE estimates 
are particularly useful for low- and middle income coun-
tries that may not have such data readily available.
In this paper we describe a process whereby country 
data sets were gathered and multivariate regression anal-
ysis was used to explore the determinants of variability in 
unit costs, in order to produce updated WHO-CHOICE 
estimates.
The previous round of WHO-CHOICE results for 
facility cost are henceforth referred to as “the first round 
analysis” [3, 8, 9]. Estimates are publicly available (http://
www.who.int/choice) and have been widely used by 
researchers, academics and analysts at both global and 
country level [10, 11]—for example publications see 
http://who.int/choice/documents/en/).
Methods
The “Methods” section first describes the data collection 
process followed by the econometric analysis.
Data collection
As a first step a literature review was undertaken with the 
aim of identifying variables and methods that should be 
taken into account during data collection and analysis 
[12].
Experience from prior work suggested that on the 
ground ‘bottom-up’ facility-level estimation is not a cost-
effective approach for producing large data sets, given 
the large costs involved with primary data collection. 
Instead we made use of existing data for secondary anal-
ysis. Cost data were gathered 2009–2010 through three 
mechanisms:
a. Authors identified through the literature review were 
directly contacted;
b. A public call went out for cost data; and
c. Websites of public institutions were searched for 
publicly available data.
The majority of data was gathered from respondents 
to the public call. Most of the sources identified through 
the literature review did not report facility-specific unit 
costs estimates, but instead presented only the sample 
average. Therefore, data from only two studies identified 
though the literature review were ultimately included in 
the estimation dataset (Additional file 1: Annex S1). In-
depth examination of available online public data bases 
revealed limited usefulness of such data as they gener-
ally lacked several of the variables required to inform the 
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analysis. Only one database found on-line was considered 
useful for extracting data [13].
The public call for cost data was released and widely 
disseminated on leading academic and international 
development websites in early 2009. The public call asked 
respondents to provide datasets of unit costs from at 
least 30 health facilities at any level (primary, second-
ary, tertiary or a mix). The data request covered a range 
of indicators, including: average unit costs (per bed day, 
admission and outpatient visit); the breakdown of each 
unit cost estimate by input category (salary, drugs, other 
supplies, capital), the proportion of recurrent to total 
costs, the proportion of drugs to recurrent costs, the pro-
portion of ancillary costs to recurrent costs; average and 
recurrent unit costs of laboratory tests and diagnostic 
procedures; various determinants of costs and efficiency 
(e.g. average length of stay, occupancy rate, bed turn 
over, number of medical staff per bed, number of out-
patient visits per medical staff per day, number of beds); 
and utilization data (e.g. number of bed days, number of 
admissions, number of outpatient visits and number of 
ancillary services by type of service).
Respondents to the public call were sent a scoping 
questionnaire to assess the type of information avail-
able. Out of 60 proposals, and considering geographic 
and income-level representation, a total of 30 respond-
ents were sent the final data collection form of which 
27 provided final data sets and were remunerated. Most 
respondents worked at public institutions and had access 
to data on resource use per facility, which had originally 
been collected to inform provider payment schemes and/
or to monitor health system performance.
A standard template was used for extracting data. The 
range of variables collected drew upon earlier work, [3, 8, 
9] and included facility size, level of care (Box 1), public/
private affiliation (Box 1), number of available beds, num-
ber of outpatient visits, number of staff (by category), 
reference year for cost data, and a breakdown of costs 
into various components including medicines, salaries, 
laboratory and soforth; as well as the estimated split in 
costs between outpatient care and inpatient care, if avail-
able (see Additional file 1: Annex S2 for a complete list of 
variables).
Data was collected with a specific intention to assess 
capacity utilization as an explanatory variable [3]. Higher 
capacity utilization should result in lower predicted unit 
cost, as fixed costs are spread across a greater number of 
outputs. For inpatient care we collected data on the per-
centage of beds occupied, while for outpatient care, we 
collected data on total number of patient visits and total 
number of staff, in order to calculate the number of visits 
per provider per day as a capacity measure.
Respondents’ files were screened for data quality 
and consistency with the requested data format. Unit 
costs were extracted from the data files. Quality control 
mechanisms included recalculation of the service deliv-
ery inpatient and outpatient cost in accordance with the 
research protocol and instructions sent to data providers. 
Data cleaning comprised consistency checks and when 
needed was followed by discussions with data suppliers 
to ensure that the data submitted corresponded to stand-
ard definitions and requested specification. Some of the 
missing variables were directly derived, when possible, 
from other variables from the same observation point 
(e.g. occupancy rate calculated from number of beds and 
number of bed-days).
Data was gathered for a total of 30 countries. Sample 
size ranged from 9 to 6725 (median 36) observations for 
health centres per country-specific dataset, and from 1 
to 4938 observations for hospitals (median 42, see Addi-
tional file 1: Annex S1 for details). One observation rep-
resents one facility in a given year.
Data collection and cleaning resulted in a dataset that 
was significantly (six times) larger compared to the previ-
ous WHO-CHOICE facility cost database. The majority 
of new cost data referred to year 2007. Costs collected in 
local currency units were converted to 2007 International 
dollars by means of Gross Domestic Product (GDP) 
deflators [14] and purchasing-power-parity exchange 
rates.
Box 1 Definition of facility level and ownership/
affiliation
Five levels of care were considered
1. Health centres with outpatient services only (no 
beds)
2. Health centres with beds
3. Primary-level hospital: Hospitals intended pri-
marily for treating simple cases (e.g. “district hos-
pital”)
4. Secondary-level hospital: Hospitals intended pri-
marily for treating referral cases (e.g. “specialist 
hospital”)
5. Teaching hospital: Hospitals intended primarily 
for treating referral cases, with a teaching compo-
nent (e.g. “teaching hospital”).
For further information on definition of hospital lev-
els, reference is made to Barnum and Kutzin [15].
  • Primary-level hospital: Have few specialities, 
mainly internal medicine, obstetrics-gynecology, 
paediatrics, general surgery or just general prac-
titioners; limited laboratory services are available 
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for general but not for specialized pathological 
analysis; bed size ranging from 30 to 200 beds; 
often referred to as district hospitals or first level 
referral.
  • Secondary-level hospital: Highly differentiated by 
function with five to ten clinical specialities; bed 
size ranging from 200 to 800 beds; often referred 
to as provincial hospital.
  • Tertiary-level hospital: Highly specialized staff 
and technical equipment, e.g. cardiology, ICU 
and specialized imaging units; clinical services 
are highly differentiated by function; might have 
teaching activities; bed size ranging from 300 to 
1500 beds; often referred to as central, regional or 
tertiary level hospital.
Three categories for affiliation were considered
  • Public
  • Private
  • Not for profit private providers (i.e. faith-based, 
mission, or non-governmental organization).
  • The variable is a known determinant of unit cost,
  • Measurement data for the variable are readily avail-
able,
  • The variable performs well in regression models.
Previous experience suggested that some variables are 
more capable of influencing the outcome of the analysis 
than others [3, 8, 9]. For instance, the level of the health 
facility (i.e. primary, secondary or tertiary) is a main 
determinant of cost. Other variables, such as the pro-
portion of emergency admissions, did not prove to be 
as important. Experimentation with different variables 
showed that a restricted list was preferable.
Unfortunately several country datasets had key vari-
ables missing, in particular regarding the breakdown 
of costs into components (e.g. salaries, drugs, lab tests 
and other costs), which affected the variables that could 
be used for the regressions. We explored methods for 
imputing data, but were unable to find a model specifi-
cation with imputed values that performed sensibly in 
either the regressions or with respect to simple descrip-
tive and summary statistics. Observations with missing 
essential data were therefore dropped. All 30 data sets 
were included but observations used in the final analysis 
were reduced from a total of 19,008—3407 (outpatient) 
and 9028 (inpatient)—see Additional file 1: Annex S1.
Model specification: inpatient care
The relationship between the outpatient/inpatient unit 
cost and explanatory variables was explored using mul-
tiple regression analysis—Ordinary Least Squares (OLS). 
The dependent variables and the continuous explana-
tory variables were transformed into natural logarithms. 
This has the advantage of coefficients being readily inter-
preted as elasticities. Country dummies were included in 
the models to address the impact of large data sets from 
Brazil and Colombia.
For the inpatient unit cost model the dependent vari-
able is one bed-day. The functional specification may be 
written as:
where ln IUCi is the natural log (ln) of cost per inpatient 
day in 2007 US$ in the ith facility; α0 and α1…n are the 
estimated parameters; the Xi are the explanatory vari-
ables transformed into natural logarithms for continuous 
variables; and e represents the error term.
Table  1 lists the explanatory variables included in the 
final regression.
ln IUCi = a0 + ai ·
n∑
i=1
lnXi + ei, i = 1 . . . n
Econometric analysis
STATA software was used for data analysis [16]. Com-
parison with data previously collected (i.e. for the first 
round analysis) revealed that the new data had very dif-
ferent characteristics. Some of these differences were 
due to different variables having been collected, as a 
result of further development of data collection meth-
ods and instruments. Moreover, there was strong evi-
dence of statistical heterogeneity in those variables that 
could be directly compared. As a result the old and the 
new datasets were not pooled, and regression analysis 
was performed using only the new dataset. Findings from 
the original literature review were also excluded unless 
authors had responded to the invitation to make available 
their datasets for inclusion in the analysis.
We adopted an approach derived from the economic 
literature on ‘hybrid cost functions’ [17, 18].
A log-cost function faced by a health facility is assumed 
to depend on:
  • A log-additive vector of input prices, and
  • An unknown function of:
• A set of output indicators, and
•  A set of variables indicating the facility type.
Drawing upon previous work, various logarithmic 
models were tried and tested [3, 8, 9]. Variables were cho-
sen based on the following criteria:
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Model specification: outpatient care
For the outpatient unit cost model the dependent varia-
ble is one outpatient visit. The best performing approach 
for outpatient visits examined a pooled sample of health 
centers and hospitals.
The algebraic form of the outpatient unit cost model is:
where ln OUCi is the natural log (ln) of cost per outpa-
tient visit in 2007 I$ in the ith facility; a0 and a1 are the 
estimated parameters; the Xi are the explanatory vari-
ables; and e represents the error term.
Table  2 lists the explanatory variables included in 
the final outpatient care regression. This includes an 
lnOUCi = a0 + ai ·
n∑
i=1
lnXi + ei, i = 1 . . . n
additional dummy specifically for Brazilian level 3 facili-
ties, given that data from Brazil constituted a significant 
share of the sample for this level of hospitals.
Model‑fit
The tests used for judging model validity and the good-
ness of fit included the Breusch–Pagan/Cook–Weisberg 
test for heteroskedasticity [19], Ramsey’s regression 
specification-error test for omitted variables, the tol-
erance test and its reciprocal variance inflation factor, 
plots of the residuals versus the fitted values, plots of the 
residuals versus the independent variables, plots of the 
predicted values versus the continuous independent vari-
ables, estimates of adjusted R-squared, the Akaike infor-
mation criterion, the Bayesian information criterion, and 
F-statistics of the regression model.
Table 1 Descriptive statistics of sample used for final inpatient care estimates (N = 3407)
a Dummies for hospital level are compared with level 4 facilities
b Dummies for hospital ownership are compared with private not-for profit hospitals
Description Mean SE
Ln cost per bed day Natural log of cost per bed day in 2007 I$ 181.59 241.21
Ln GDP per capita Natural log of GDP per capita in 2007 I$ 8788.86 3729.88
Ln occupancy rate Natural log of bed occupancy rate 0.23 0.33
Ln ALOS Natural log of Average Length of Stay (ALOS) 4.16 2.33
Ln admissions Natural log of total inpatient admissions 4700.00 7416.81
District Dummy variable for level 3  facilitiesa (equivalent to district hospitals) 0.80 0.40
Teaching Dummy variable for level 5 facilities (teaching hospitals)a 0.09 0
Public Dummy variable for public  hospitalsb 0.58 1
Private Dummy variable for private  hospitalsb 0.16 0
Brazil Dummy variable for Brazil. Brazil = 1 0.58 1
Table 2 Descriptive statistics of sample used for final outpatient care estimates (N = 9028)
a  Dummy for urban location is compared with rural location
b Dummies for facility ownership are compared with private not-for profit facilities
c Dummies for level of care are compared with level 1 facilities. Level 5 facilities are assumed to have the same outpatient costs as level 4 facilities
Description Mean SE
Ln cost per visit Natural log of cost per outpatient visit in 2007 I$ 15.56 44.02
Ln GDP per capita Natural log of GDP per capita in 2007 I$ 7947.64 4618.50
Ln visits Natural log of outpatient visits per facility 62,924.53 118,929.70
Ln visits per provider Natural log of visits per provider per day (nurses, general practitioners) 5.71 10.90
Urban Dummy variable for urban facility  locationa 0.21 0.41
Public Dummy variable for public  hospitalsb 0.75 0.44
Private Dummy variable for private  hospitalsb 0.12 0.32
Level 2 Dummy variable for level 2  facilitiesc 0.15 0.35
Level 3 Dummy variable for level 3  facilitiesc 0.25 0.43
Level 4 Dummy variable for level 4  facilitiesc 0.08 0.26
Colombia Dummy variable for Colombia. Colombia = 1 0.10 0.30
Brazil Dummy variable for Brazil. Brazil = 1 0.62 0.49
Brazil level 3 Dummy variable for Brazil level 3 facilities 0.18 0.39
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Robust estimation methods were used (i.e. the Stata 
command “robust”), in order to control for the effect on 
the estimate of standard errors caused by ‘clustering’ (i.e. 
the inclusion of multiple observations per country).
Predicted values and uncertainty analysis
WHO-CHOICE draws upon the prediction models 
described above to derive cost estimates for all mem-
ber states. For the prediction of unit costs for inpatient 
days and outpatient visits, we use country-specific val-
ues where possible (i.e. GDP, country-specific dummy 
variables). Other explanatory variables, particularly those 
related to capacity utilization (e.g. occupancy rate, aver-
age length of stay), rely on representative ‘average values’ 
which can be set to normative values, sample medians, or 
to other values as appropriate. These ‘average values’ have 
desirable properties that may not always be possessed 
by the sample observations for that country [3]. Lacking 
appropriate norms, we applied the 80th percentile (p80) 
values from the sample of facilities used for the final 
regression models (Table 3). This is consistent with pre-
vious rounds of WHO-CHOICE unit cost estimates for 
which a 80% capacity level has been assumed.
As a first step, regression results (coefficients and vari-
ance–covariance matrix) were used to predict country-
specific unit costs within a 95% uncertainty interval 
(UI). For the generic set of WHO-CHOICE estimates we 
assume public provision at all facility levels (however the 
model can also be set to predict private provider costs). 
The initial analysis based variables (GDP I$ per capita) on 
year 2007, since the majority of data in our dataset (92%) 
referred to this year. We have since applied the same 
model in order to derive estimates for 2010, which is a 
year consistent with the Global Burden of Disease Study 
(GBD) 2010 data [20], and thus useful for cost-effective-
ness analysis drawing upon the GBD 2010 estimates. 
Explanatory variables were based on data for 2010 (i.e. 
GDP per capita in 2010 I$) and other values described in 
Table 3.
Next, we undertook adjustments to ensure that drug 
costs were not included. Data providers had reported 
challenges relating to apportioning drug costs between 
inpatient and outpatient care. This was handled by apply-
ing a proportional adjustment ratio, derived from pre-
vious work on inpatient care [8], to the reported cost 
estimates, thus adjusting these downwards in order to 
capture only the general, standardized components of 
the facility visit and bed-day, as described above. We set 
drug dummy variables to 0 and 1 respectively in order 
to estimate the average estimated contribution of drug 
costs across countries (47.5%) in previous work [8]. A 
similar approach can be adopted for separating out food 
costs from the reported inpatient costs (9.9%) in the first 
round analysis. Due to lack of data regarding adjustment 
ratios for outpatient care related drug costs, we applied 
the ratio derived from previous inpatient care models to 
outpatient visits as well. The adjustment ratios were uni-
formly applied to the regression results across all country 
estimates.
As described in previous analysis, [8] the re-transfor-
mation of predicted log unit costs  (iuci) gives the median 
and not the mean of the distribution. One widely-used 
solution to this retransformation problem is Duan’s 
‘smearing’ method [21]). The method is non-parametric, 
because it does not require that the regression error have 
any specific distribution. A smearing factor can be esti-
mated following three steps: (i) Estimation of regression 
residuals,  ri. (ii) Exponentiation of regression residuals to 
Table 3 Values of variables used for prediction of the unit cost
For definition of levels of care see Box 1
a Outpatient visit costs at level 5 are assumed to be the same as those for level 4
Inpatient care Proxy for size Proxy for capacity Proxy for intensity of care provided
Total inpatient admissions per facility 
per year (p80)
Bed occupancy rate (p80) Average length of stay, inpatient (p80)
Facility level 3 4971 0.756 7.14
Facility level 4 and 5 14,028 0.810 9.75
Outpatient care Total outpatient visits per facility per year (p80) Visits per provider per day (p80)
Facility level 1 67,656 8.96
Facility level 2 46,434 9.52
Facility level 3 93,739 3.22
Facility level 4 and  5a 281,156 2.36
Additional variables
 Ownership is set to public provider; location is set to urban location for outpatient care
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the power e, exp(ri). (iii) Averaging of the exponentiated 
residuals 1/n *∑exp(ri). The smearing factor is then mul-
tiplied by the re-transformed log unit costs (i.e. exp(ci)). 
This is the method applied in the Excel-based WHO 
CHOICE tools, which are available for countries to make 
their own predictions.
Unfortunately, Duan’s method requires that the distri-
bution of the errors be homoscedastic. To test the sen-
sitivity of our best estimates to this assumption and to 
construct 95% UIs, we employed a Bayesian approach. 
For each log prediction, we used the mean and standard 
error to draw 1000 random values, exponentiated each of 
these 1000 values and then extracted the mean, standard 
deviation and 2.5th and 97.5th centile values. For outpa-
tient care, the two retransformation methods produced 
unit cost estimates that were equivalent on average. For 
inpatient care, the Bayesian approach produced unit cost 
estimates that were 4% higher on average. Given that the 
95% UIs overlapped with estimates produced by Duan’s 
method, we present country-specific estimates obtained 
using the Bayesian approach.
Results
Descriptive statistics
Tables  1 and 2 show the variable names, description, 
mean and standard error for the data sets on inpatient 
and outpatient care respectively.
Explanatory power
Tables 4 and 5 show the final regression models for inpa-
tient and outpatient unit costs with 95% confidence inter-
vals. All variables are significant, with most variables 
highly significant with p < 0.001. The inpatient cost model 
is slightly better performing with an adjusted R squared 
of 0.760 compared to 0.658 for the outpatient care model.
Signs of the coefficients are consistent with expecta-
tions in both models, with more detailed interpreta-
tion below. In both models, GDP per capita is a highly 
significant proxy for price level but also for the level of 
technology.
Level and location of facilities
As expected, costs are higher in higher level, and urban, 
facilities. The level of facility is significant for both inpa-
tient and outpatient care costs, with p < 0.001 for all lev-
els. With regards to inpatient care, specialist and teaching 
hospitals (levels 4 and 5) have higher estimated unit cost 
than district hospitals (level 3). Urban/rural location is 
significant for outpatient care costs, with higher unit 
costs in urban settings.
Size of facilities
The size of facilities providing inpatient care is measured 
by the number of admissions (used instead of number of 
beds as the latter was highly collinear with the occupancy 
rate). This parameter has a very small, but still significant 
(p < 0.05) positive effect on inpatient costs. The small 
effect on cost can be said to result from mixed effects 
because, on the one hand, higher admissions could lead 
to lower overhead cost per patient and greater efficiency 
while, on the other hand, greater size could also indicate 
more specialist care with a larger proportion of com-
plicated cases and thus a higher unit cost. The proper 
identification of the effect size would require more infor-
mation of the capacity at which the facility is operating, 
and more detailed data on resource use at the level of 
the specialized units within each facility. For outpatient 
costs, the number of visits per year was used as an indica-
tor of size, and here the results align with our expecta-
tions that larger facilities would have lower costs, likely 
due to operating with more efficient provision of care 
(significant at p < 0.05).
Table 4 Regression coefficients and 95% confidence inter-
val: natural log of cost per inpatient bed day expressed 
in 2007 I $
Note only facilities of types 3, 4 and 5 are included in this regression model
* p < 0.05, ** p < 0.01, *** p < 0.001
Regression coefficient 95% confidence 
interval
Ln GDP per capita 1.192*** [1.111, 1.272]
Ln occupancy rate − 0.0201** [− 0.0340, 
− 0.00623]
Ln ALOS − 0.600*** [− 0.649, − 0.550]
Ln admissions 0.0252* [0.00471, 0.0457]
District − 0.204*** [− 0.275, − 0.132]
Teaching 0.257*** [0.163, 0.351]
Public − 0.144*** [− 0.182, − 0.107]
Private 0.110*** [0.0710, 0.148]
Brazil − 1.638*** [− 1.694, − 1.583]
Constant − 4.277*** [− 5.035, − 3.519]
Observations 3407
R2 0.760
Adjusted R2 0.760
F_stat 1070.3
Duan’s correction factor 1.054
Variance inflation factor 1.721
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Ownership
Compared to facilities run by not for profit private pro-
viders (i.e. missions or non-governmental organizations), 
unit costs are predicted to be lower for both outpatient 
and inpatient care in public facilities (p < 0.01 in both 
models). Both models also indicate higher costs in pri-
vate for profit facilities (highly significant at p < 0.01 for 
inpatient care, and somewhat less significant at p < 0.05 
for outpatient care). These results align with our expecta-
tions [22, 23].
Capacity utilization
The models confirm measures of capacity utilization as 
important explanatory variables of cost [3]. A higher bed 
occupancy rate should result in lower inpatient bed day 
cost, as fixed costs are spread across a greater number of 
outputs. This effect is confirmed by the inpatient model 
(p < 0.01). A longer average length of stay (ALOS) is sig-
nificantly associated with lower inpatient bed day cost 
(p < 0.001), presumably because fixed costs are spread 
over a greater number of days. A greater number of visits 
per provider per day significantly reduces the outpatient 
cost (p < 0.001), more so than the number of visits per 
facility.
Country dummies
Country dummies were included only where their effect 
was significant, which is the case for both inpatient costs 
where Brazil observations constitute 58% of the entire 
sample, and outpatient costs where Brazil makes up as 
much as 62% of observations included in the final model. 
For outpatient care we also included a dummy variable 
for Colombia. All dummies for Brazil and Colombia are 
highly significant at p < 0.001.
Comparison with earlier models
The regression model for inpatient care differs from the 
earlier WHO-CHOICE prediction model in that vari-
ables for food and drug costs are not included [8]. On the 
other hand we included other variables that have been 
reported in hospital cost function estimation literature, 
such as the average length of stay [24, 25].
The model for outpatient care is significantly different 
from the previous WHO-CHOICE models, in that the 
new model differentiates between levels of care.
Validation
For internal validation purposes we produced scatter 
graphs of actual and predicted observations by facility 
type and examined these closely for every country. As 
described above, predicted values were based on the 80th 
percentile of variables used for prediction (Table 3).
Figure 1 plots the predicted values from the outpatient 
model against the unit cost data and the level of GDP per 
capita, for all level 1 facilities for the countries included 
in the sample. The line represents the predicted values of 
the cost per visit (in natural logs), estimated for a public 
facility using assumptions outlined in Table 3.
Figure  2 similarly plots the predicted values for inpa-
tient service delivery costs against the country supplied 
estimates and the level of GDP per capita, for level 3 
facilities. The predicted costs reflect the regression analy-
sis and as such represent an average relationship between 
cost determinants, whereas the actual country values 
demonstrate a significant spread due to facility-specific 
conditions.
The figures confirm that the models have a reasonable 
fit with the data and illustrate the considerable variabil-
ity in the observed unit costs within individual countries 
(each column of dots represents a country with a specific 
GDP per capita).
Moreover, we attempted to validate the predicted 
CHOICE cost estimates against cost data on TB and 
HIV-related health services (outpatient visits) which had 
been collected through country-specific research studies 
by WHO’s TB department and UNAIDS. While meth-
odological differences between studies makes a direct 
Table 5 Regression coefficients and 95% confidence 
interval: natural log of cost per outpatient visit expressed 
in 2007 I $
* p < 0.05, ** p < 0.01, *** p < 0.001
Coefficient 95% confidence interval
Ln GDP per capita 0.865*** [0.826, 0.905]
Ln visits − 0.0142* [− 0.0272, − 0.00119]
Ln visits per provider − 0.0412*** [− 0.0578, − 0.0246]
Urban 0.352*** [0.268, 0.435]
Public − 0.290*** [− 0.330, − 0.249]
Private 0.0532* [0.00479, 0.102]
Level 2 0.208*** [0.144, 0.271]
Level 3 0.304*** [0.213, 0.395]
Level 4 0.348*** [0.279, 0.417]
Colombia 0.628*** [0.542, 0.713]
Brazil − 1.563*** [− 1.656, − 1.470]
Brazil level 3 − 0.245*** [− 0.337, − 0.153]
Constant − 4.534*** [− 4.797, − 4.271]
Observations 9028
R2 0.658
Adjusted R2 0.658
F_stat 1635.7
Duan’s correction factor 1.271
Variance inflation factor 3.209
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comparison challenging, the comparison indicated that 
estimates were in the same range.
The models outlined here are used to derive predic-
tions at country and WHO region level. Table 6 presents 
the predicted values for public hospitals in selected coun-
tries using Table  3 assumptions and 95% uncertainty 
intervals. The estimates are presented in 2010 I$, based 
on the 2010 GDP per capita in I$. Table 6 and Fig. 2 illus-
trate the comparatively lower estimates derived from the 
data samples from Brazil and the United States of Amer-
ica. Additional predictions are available from the WHO-
CHOICE website: http://www.who.int/choice.
We examined our data set for the reported shares 
of drug costs which were 10.6% for outpatient care 
(N = 5478 out of 9028) and 5.3% for inpatient care (2688 
out of 3407). While these are likely underestimates, we 
ran a sensitivity analysis using these shares, with results 
reported in Table 7.
Discussion
This paper describes the most recent effort by WHO 
to develop models to predict country-specific costs for 
outpatient visits and inpatient bed days. The database 
of country-specific cost estimates is a public good pro-
vided by WHO which serves a unique purpose at global, 
regional, and country level, allowing analysts to easily 
access data and apply these within a range of analytical 
settings—including economic evaluation, cost of illness 
studies, investment cases and resource needs appraisals.
The models presented in this paper were informed by 
data gathered through a thorough search for databases 
that reported costs at a range of facilities. Data imputa-
tion techniques were explored but not used, given that 
they reduced the performance of the models according 
to statistical and validation tests when compared to mod-
els not including imputed values. This probably indicates 
that data sets with missing values are less reliable than 
Fig. 1 Predicted values (regression lines) for outpatient service delivery costs in level 1 facilities, 2007 I$, plotted against the natural log of GDP per 
capita (X axis). (Y-axis shows the raw data for cost per visit in natural logs) N = 4750. Natural logarithm of outpatient unit costs expressed in 2007 I$. 
ARM Armenia, BFA Burkina Faso, BRA Brazil, COL Colombia, GEO Georgia, GHA Ghana, ECU Ecuador, IDN Indonesia, MDA Moldova, NGA Nigeria, MNG 
Mongolia, PAK Pakistan, PHL Phillippines, RWA Rwanda, SRL Sri Lanka, USA USA
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other data, which further suggests that a ‘missing at ran-
dom’ assumption is inappropriate for this sample.
The variables included in the models have high sta-
tistical significance and the signs of the coefficients are 
consistent with results from previously published mod-
els. While there is a significant variation at country 
level (Figs.  1, 2), the model clarifies how such variation 
may be due to type/level of facility, facility size, owner-
ship, and current capacity utilization. While a substantial 
portion of the observed variability can be explained by 
the specified determinants, some unexplained variabil-
ity remained, possibly due to factors that we could not 
measure such as case mix (variation in diagnosis), quality 
of care, and incentive structures.
The majority of data points that the model draws upon 
refer to year 2007. While technology may have since 
evolved, the revised WHO CHOICE estimates presented 
here provide a valuable resource and more recent esti-
mates compared to previous analysis. It is recommended 
that new rounds of data collection be conducted in the 
future to guide further model updates. In the interim 
however, the current model provides researchers and 
analysts with a set of comparative cost estimates not 
found elsewhere. Moreover, additional future work will 
be needed to improve cost estimates for outreach and 
community service delivery platforms which are impor-
tant in particular for prevention activities.
Comparison with estimates derived from previous 
WHO‑CHOICE prediction models
As expected, when compared with the previous round of 
WHO-CHOICE models, [3, 8, 9] the models presented 
here result in predicted costs that are higher in most 
cases, particularly for outpatient care. The background 
technical report provides more information on compara-
tive statistics between the past and current set of mod-
els [26]. Higher costs from the current set of models are 
expected due to changes in technology as well as general 
price inflation.
The updated estimates are based on data from fewer 
countries than the previous WHO-CHOICE regression 
analysis (30 compared to 80). However, when considering 
Fig. 2 Predicted values (regression lines) for inpatient service delivery costs in level 3 facilities, 2007 I$, plotted against the natural log of GDP 
per capita (X axis). (Y-axis shows the raw data for cost per inpatient bed day in natural logs) N = 5037. Natural logarithm of inpatient unit costs 
expressed in 2007 I$. ARM Armenia, BEN Benin, BFA Burkina Faso, BRA Brazil, COL Colombia, CMR Cameroon, GEO Georgia, GHA Ghana, ECU Ecuador, 
IDN Indonesia, KGZ Kyrgyzstan, LBN Lebanon, MDA Moldova, MNG Mongolia, NGA Nigeria, NLD Netherlands, PAK Pakistan, PHL Philippines, RWA 
Rwanda, SRL Sri Lanka, SRB Serbia, THA Thailand, UGA Uganda, USA USA, ZMB Zambia
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Table 6 Predicted service delivery cost per bed-day (i) for selected countries (2010 I$)
(i) Cost per bed day is estimated for public hospitals, excluding the cost of drugs but including costs such as personnel, capital and food costs
For definition of levels of care see Box 1
List of countries for which estimates are reported here is the same as was reported in Adams et al. [8], with the addition of Brazil and United States of America, which 
represent large shares of the data sample
SD standard deviation
Country (ranked by GDP 
per capita)
GDP per capita (I$) Hospital level Cost per bed day (I$)
Mean 95% uncertainty interval 
low
95% uncertainty interval 
high
SD
Mozambique 894 3 6.97 2.74 15.29 3.15
4 7.46 2.81 15.58 3.37
5 9.76 3.56 21.80 4.62
Mali 1215 3 10.17 4.05 21.49 4.72
4 10.78 4.21 22.94 4.99
5 14.40 5.45 30.34 6.59
Indonesia 4298 3 46.61 19.03 102.61 21.68
4 48.61 19.83 102.41 20.87
5 62.97 23.33 139.86 28.97
Algeria 8029 3 98.15 104.21 134.41 35.25
4 104.21 134.41 35.25 38.34
5 134.41 35.25 38.34 52.49
Ecuador 8795 3 105.79 41.16 215.84 46.98
4 113.27 44.88 244.39 53.20
5 151.41 61.03 322.49 68.84
Brazil 11,187 3 27.96 11.31 63.05 12.85
4 30.18 11.46 63.20 13.44
5 37.96 14.63 78.69 16.61
Romania 14,815 3 202.22 79.57 439.38 93.24
4 210.68 88.23 466.93 96.38
5 272.20 104.03 577.31 123.74
Bahrain 20,339 3 290.75 305.89 400.24 117.36
4 305.89 400.24 117.36 118.35
5 400.24 117.36 118.35 153.11
Russian Federation 20,593 3 296.04 106.32 648.53 138.93
4 313.35 114.96 678.27 154.36
5 407.34 153.69 925.76 197.33
Greece 27,545 3 437.22 162.5 943.81 209.06
4 441.67 174.11 960.97 196.38
5 569.30 226.01 1206.52 260.50
United Kingdom 35,433 3 570.07 217.32 1265.39 267.32
4 612.29 218.78 1397.20 299.66
5 767.92 289.87 1664.19 367.70
Canada 39,176 3 646.49 237.17 1461.88 299.35
4 680.16 266.49 1532.70 317.30
5 869.98 331.92 1869.47 403.22
United Arab Emirates 42,180 3 719.15 272.51 1625.10 357.52
4 740.80 294.82 1629.96 338.45
5 952.57 381.38 2097.89 426.29
United States of America 46,747 3 788.50 293.85 1700.93 381.24
4 834.13 318.51 1789.65 375.56
5 1093.51 415.16 2426.98 535.63
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Table 7 Predicted service delivery cost per bed-day and outpatient visit for selected countries, using different ratios 
for drug cost adjustment
Costs are estimated per bed day for public health facilities, excluding the cost of drugs. a Standard drug share uses 47.5% assumption for medicines b Lower 
drug shares were derived from the sample as 10.6% for outpatient care and 5.3% for inpatient care. For definition of levels of care see Box 1. Cost estimates were 
transformed from I$ to US$ using exchange rates for 2010 available from World Development Indicators (Accessed 19 September 2017)
Country GDP per capita (I$) Facility level Cost per outpatient visit Cost per inpatient bed day
Mean (with stand‑
ard drug % share)a
Mean (with lower 
drug % share)b
Mean (with stand‑
ard drug % share)a
Mean (with lower 
drug % share)b
2010 I$ 2010 USD 2010 I$ 2010 USD 2010 I$ 2010 USD 2010 I$ 2010 USD
Mozambique 894 1 2.2 1.0 3.7 1.7
– 2 2.7 1.2 4.5 2.1
– 3 3.1 1.4 5.2 2.4 7.0 3.2 12.9 6.0
– 4 3.2 1.5 5.4 2.5 7.5 3.5 13.5 6.3
– 5 3.2 1.5 5.4 2.5 9.8 4.6 17.4 8.1
Mali 1215 1 4.0 1.5 6.8 2.6
– 2 4.8 1.9 8.2 3.2
– 3 5.6 2.2 9.5 3.7 10.2 3.9 18.6 7.2
– 4 5.7 2.2 9.7 3.7 10.8 4.2 19.3 7.5
– 5 5.8 2.2 9.9 3.8 14.4 5.6 25.0 9.7
Indonesia 4298 1 15.0 5.7 25.6 9.6
– 2 18.5 7.0 31.4 11.8
– 3 20.7 7.8 35.2 13.3 46.6 17.6 83.1 31.3
– 4 21.2 8.0 36.1 13.6 48.6 18.3 88.4 33.3
– 5 20.9 7.9 35.6 13.4 63.0 23.7 113.1 42.6
Algeria 8029 1 21.6 7.6 36.8 13.0
– 2 25.0 8.9 42.6 15.1
– 3 29.5 10.4 50.3 17.8 98.2 34.7 176.3 62.4
– 4 30.6 10.8 52.1 18.5 104.2 36.9 186.4 66.0
– 5 31.5 11.2 53.7 19.0 134.4 47.6 234.2 82.9
Brazil 8795 1 4.8 3.8 8.2 6.5
– 2 5.8 4.5 9.8 7.7
– 3 5.4 4.2 9.2 7.2 28.0 22.0 51.2 40.3
– 4 7.0 5.5 12.0 9.4 30.2 23.8 52.7 41.6
– 5 6.9 5.5 11.8 9.3 38.0 29.9 67.2 52.9
Romania 14,815 1 27.9 13.5 47.5 22.9
– 2 33.8 16.3 57.5 27.8
– 3 37.5 18.1 63.8 30.8 202.2 97.7 371.4 179.4
– 4 40.6 19.6 69.2 33.4 210.7 101.7 384.1 185.5
– 5 41.1 19.8 69.9 33.8 272.2 131.5 493.0 238.1
Russian Federation 20,593 1 31.9 16.6 54.3 28.3
– 2 38.8 20.2 66.0 34.4
– 3 42.4 22.1 72.3 37.6 296.0 154.2 537.4 279.9
– 4 46.2 24.1 78.7 41.0 313.4 163.2 561.3 292.3
– 5 47.3 24.7 80.6 42.0 407.3 212.1 741.0 385.9
United Arab Emirates 56,415 1 77.1 47.9 131.3 81.6
– 2 95.9 59.6 163.3 101.5
– 3 109.5 68.0 186.4 115.8 719.2 446.8 1275.1 792.2
– 4 108.8 67.6 185.2 115.1 740.8 460.2 1299.2 807.2
– 5 112.6 70.0 191.8 119.2 952.6 591.8 1726.3 1072.5
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the considerable variation in unit costs reported within 
countries the recommendation is that a sufficiently 
large number of facilities within a country is required to 
ensure representativeness [9]. Therefore, if one considers 
only datasets with 10 or more observations, the number 
of datasets in the two analyses are similar (30 in the new 
analysis compared to 33 in the first round) and can thus 
be considered similarly representative of between-coun-
try variation. With a higher average number of facilities 
per country, the new dataset is more representative of 
within-country variation. A significant limitation in the 
new round of analysis is however the lack of outpatient 
cost data from high-income countries. The effect of this 
feature of the data on the comparability of cost estimates 
across both hospitals and health centers is unknown.
Caveats
Unit cost estimates are sensitive to the method used for 
cost allocation [27, 28]. Most data collectors reported 
using a bottom up approach (53% of sample, with 14% 
using a top-down approach and 33% not providing infor-
mation, data not shown). The list of variables collected 
varied across settings, which is expected as costs would 
have been collected for different purposes. Neverthe-
less this posed challenges for our aggregate analysis. A 
particular challenge concerned overhead costs, where 
analysts included different components, which makes it 
likely that some respondents underestimated overhead 
costs. Another challenge was health worker salaries, 
where analysts reported encountering difficulties locating 
relevant cost data, particularly in public sector settings 
where managers have limited information on salaries of 
their fellow co-workers. A few respondents reported allo-
cation between inpatient and outpatient care based on 
revenue generation rather than resource use. Estimates 
were pooled even when revenue generation was reported.
Data providers should be better equipped to extract 
commodity costs from their estimates. The use of a uni-
form ratio across countries to remove food- and/or drug 
related costs is a limitation, as the ratio of drugs relative 
to other costs would presumably vary across settings 
[29, 30]. Moreover, the average contribution of drug 
costs derived from previous work (47.5%) is higher than 
expected. The World Health Report 2010 reported that 
pharmaceuticals account for 20–30% of all global health 
spending [1]. Nevertheless, the 47.5% assumption is 
retained for this round of CHOICE estimates. Table  7 
provides a sensitivity analysis highlighting the impact of 
this assumption.
Similarly, measures around performance of health facil-
ities and overall capacity should be incorporated during 
cost data collection processes. The above challenges are 
a result of using secondary data sources but nevertheless 
point to lack of standardised data collection and report-
ing processes.
User‑defined parameters
Our choice of admissions as the size measure for hospi-
tals may be critiqued in that this reflects short-run out-
put volume variations while hospital beds would better 
reflect installed capacity [31].
Moreover, in order to derive a standard set of WHO-
CHOICE cost estimates (Table  4) we applied specific 
assumptions derived from the data sample, for facilities 
operating at the 80% percentile of a sample of similar such 
facilities in terms of capacity utilization and output. It is 
possible the 80% percentile values do not correspond to 
performance at 80% capacity, but unfortunately the data 
does not allow for verification of this. On the assumption 
that many facilities in low and middle income countries 
operate at low capacity, our prediction values may be too 
low, which would overestimate costs for a system oper-
ating at 80% capacity. A spreadsheet model is available 
through the WHO-CHOICE website for those who wish 
to adjust the parameters used and generate their own 
country specific estimates (http://who.int/choice/cost-
effectiveness/inputs/en/), for example in relation to facili-
ties that are private for profit, or facilities located in rural 
areas. Different assumptions for the predictor variables 
(e.g. average length of stay, number of patients seen per 
provider per day, etc.) may be used, although it is recom-
mended that unit costs for economic evaluations should 
reflect technically and economically efficient service pro-
vision [32].
Conclusions
WHO-CHOICE health service delivery unit costs are 
unique and considered a standard data source for eco-
nomic analysis, used by analysts all over the world. With 
the new models, unit cost estimates have been produced 
for all 14 WHO epidemiological sub-regions (and 21 
regions used by the IHME for Global Burden of Disease 
Project) [33], using population-weighted GDP per capita. 
The models can predict country-specific unit costs at dif-
ferent capacity levels and in different settings. Country 
and region estimates are available through the WHO-
CHOICE website, along with tools that allow users to 
adjust variables and make their own predictions [34].
With the SDGs there is a call to action to maxim-
ise the efficiency of data collection, and for informed 
and accountable decision making [35]. Resource alloca-
tion should be based on informed analysis with regards 
to costs and benefits. It is therefore critically important 
that national and local governments as well as the inter-
national community strengthen efforts to collect, analyse, 
and make use of information on health system resource 
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use and efficiency. Efforts should be made to integrate 
cost information in general data collection efforts. For 
example, the World Bank’s Service Delivery Indicators 
program has been collecting facility-level data on per-
formance and quality of service delivery indicators for a 
limited number of countries in Africa (Kenya, Senegal, 
Tanzania and Uganda) but to our knowledge has not 
focused on service costs [36]. Similarly with the District 
Health Information Software (DHIS2) software plat-
form being used in a large number of countries, there is 
now ongoing work to assess how information on facility 
level resource use can be regularly captured and used to 
inform decision making. Countries should develop sys-
tematic data collection systems to store, transfer and pro-
duce robust and up to date strategic financial information 
for stakeholders at local, sub-national and national levels 
[2].
There is a need to strengthen capacity to understand 
and make use of data at country level, in particular in 
low-income countries where resources are limited and 
the use of economic and financial data for evaluating 
current system performance could lead to considerable 
efficiency gains [1]. The WHO-CHOICE project makes 
tools, models and datasets available for county users and 
has recently invested in the enhanced user-friendliness of 
the suite of cost-effectiveness tools through their incor-
poration into the Spectrum platform, and a built-in link 
to the OneHealth Tool—a joint UN resource projection 
tool used in over 40 countries [37].
While the WHO-CHOICE project provides robust 
defaults for countries to assess costs at five levels of ser-
vice delivery, future modelling work should consider 
additional delivery modes such as community based 
delivery and outreach. More research may be needed 
regarding the assumptions used for continuous inde-
pendent predictor variables in order to derive country 
predicted values, and guidance regarding setting norms 
for capacity utilization.
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